Clinical Trials Logo
  1. Home
  2. Pancreatic Disease
  3. NCT05743972

Contrast-Enhanced Ultrasound vs Conventional US-guided Percutaneous Needle Biopsy for Pancreatic Diseases: Prospective Multicenter Randomized Controlled Trial

Pancreatic Disease Clinical Trial

Official title:
Contrast-Enhanced Ultrasound vs Conventional US-guided Percutaneous Needle Biopsy for Pancreatic Diseases: Prospective Multicenter Randomized Controlled Trial

Clinical Trial Summary

According to previous studies, contrast-enhanced ultrasound (CEUS) -guided Core Biopsy(GB) could improve the diagnosis of biopsy in liver and other superficial mass compared to conventional US-GB. The purpose of this randomized trial is to estimate whether CEUS-GB achieve excellent diagnostic value to conventional US-GB in percutaneous biopsy for pancreatic diseases.

Clinical Trial Description

The patients with pancreatic diseases who need receive percutaneous biopsy were randomized with 1:1 ratio into undergo CEUS-GB group and conventional US-GB group.The aims include: Comparison the diagnostic accuracy rate between CEUS and US group. Comparison the diagnostic specificity, sensitivity and complication rate between CEUS and US group. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05743972
Study type Interventional
Source First Affiliated Hospital, Sun Yat-Sen University
Contact Xiaoyan Xie, M.D.
Phone 86-20-87765183
Email xiexyan@mail.sysu.edu.cn
Status Not yet recruiting
Phase N/A
Start date March 1, 2023
Completion date February 1, 2026
View Details
See also
  Status Clinical Trial Phase
Completed NCT01997476 - EUS Ductal Evaluation in One Endoscopic Session for the Diagnosis of Exocrine Pancreas Disease N/A
Recruiting NCT05429203 - Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope N/A
Completed NCT01087801 - A Study of Synthetic Human Secretin (ChiRhoStim®) Administered Intravenously to Stimulate Exocrine Pancreas Fluid Secretion for Collection Via Endoscope and Laboratory Analysis of DNA Markers Phase 3
Active, not recruiting NCT05253859 - CFTR Modulators and Gastrointestinal Complications
Recruiting NCT00830557 - Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
Recruiting NCT04949282 - Spanish Series of Patients Treated With the Radionuclide Lutetium177
Recruiting NCT06340620 - EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope N/A
Recruiting NCT01580527 - Postoperative Artificial Nutrition After Pancreaticoduodenectomy N/A
Completed NCT01368094 - Early (4 Days) Versus Standard Drainage of the Abdominal Cavity After Pancreaticoduodenectomy N/A
Recruiting NCT05832047 - Aggressive Hydration With Lactated Ringer's Solution Versus Plasma Solution for the Prevention of Post ERCP (Endoscopic Retrograde Cholangiopancreatography) Pancreatitis Phase 4
Completed NCT05068739 - Needle Knife Fistulotomy Versus Partial Ampullary Endoscopic Mucosal Resection for Difficult Biliary Cannulation N/A
Completed NCT02638818 - Outcomes in Minimally Invasive Versus Open Pancreaticoduodenectomy
Recruiting NCT04932785 - Regular vs. Clear Liquid Diet for Mild to Moderate Acute Pancreatitis N/A
Recruiting NCT05457101 - Validation of an AI-based Biliopancreatic EUS Navigation System for Real-time Quality Improvement: A Prospective, Single-center, Randomized Controlled Trial N/A
Recruiting NCT05515705 - First-in-human Navigation Endoscopic Ultrasound (EUS) System Clinical Study N/A
Recruiting NCT05251467 - A Comprehensive Approach To Relief Of Digestive Symptoms In Cystic Fibrosis: CARDS-CF
Withdrawn NCT00663975 - Open Label Safety Study of DCI-1020 in Pediatric Cystic Fibrosis (CF) Patients N/A
Enrolling by invitation NCT05051358 - Therapeutic Endoscopic Ultrasound for Gastrointestinal Disorders: A Multicenter Registry Study
Recruiting NCT03809247 - Microbial Diversity of Pancreatic Diseases
Recruiting NCT05193162 - Retrospective Study on Microbial Diversity in Paraffin Tissue of Pancreatic Diseases